Logo image of ALBKK.PA

BAIKOWSKI SAS (ALBKK.PA) Stock Fundamental Analysis

EPA:ALBKK - Euronext Paris - Matif - FR0013384369 - Common Stock - Currency: EUR

19.198  +1 (+5.48%)

Fundamental Rating

5

ALBKK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 62 industry peers in the Chemicals industry. ALBKK has an average financial health and profitability rating. ALBKK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALBKK had positive earnings in the past year.
ALBKK had a positive operating cash flow in the past year.
Each year in the past 5 years ALBKK has been profitable.
ALBKK had a positive operating cash flow in each of the past 5 years.
ALBKK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBKK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

ALBKK's Return On Assets of 5.47% is fine compared to the rest of the industry. ALBKK outperforms 71.88% of its industry peers.
The Return On Equity of ALBKK (8.28%) is better than 62.50% of its industry peers.
With a Return On Invested Capital value of 3.85%, ALBKK perfoms like the industry average, outperforming 57.81% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALBKK is in line with the industry average of 6.29%.
Industry RankSector Rank
ROA 5.47%
ROE 8.28%
ROIC 3.85%
ROA(3y)5.5%
ROA(5y)5.78%
ROE(3y)8.43%
ROE(5y)9.14%
ROIC(3y)4.4%
ROIC(5y)4.46%
ALBKK.PA Yearly ROA, ROE, ROICALBKK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ALBKK's Profit Margin of 7.95% is fine compared to the rest of the industry. ALBKK outperforms 73.44% of its industry peers.
In the last couple of years the Profit Margin of ALBKK has grown nicely.
The Operating Margin of ALBKK (6.12%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALBKK has remained more or less at the same level.
ALBKK's Gross Margin of 58.07% is amongst the best of the industry. ALBKK outperforms 87.50% of its industry peers.
ALBKK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.12%
PM (TTM) 7.95%
GM 58.07%
OM growth 3Y-22.94%
OM growth 5Y-0.34%
PM growth 3Y-19.29%
PM growth 5Y4.18%
GM growth 3Y-5.48%
GM growth 5Y-1.45%
ALBKK.PA Yearly Profit, Operating, Gross MarginsALBKK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

ALBKK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALBKK has about the same amount of shares outstanding.
Compared to 5 years ago, ALBKK has about the same amount of shares outstanding.
ALBKK has a better debt/assets ratio than last year.
ALBKK.PA Yearly Shares OutstandingALBKK.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALBKK.PA Yearly Total Debt VS Total AssetsALBKK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ALBKK has an Altman-Z score of 3.74. This indicates that ALBKK is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.74, ALBKK is doing good in the industry, outperforming 76.56% of the companies in the same industry.
The Debt to FCF ratio of ALBKK is 5.76, which is a neutral value as it means it would take ALBKK, 5.76 years of fcf income to pay off all of its debts.
ALBKK has a better Debt to FCF ratio (5.76) than 65.63% of its industry peers.
ALBKK has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALBKK (0.18) is better than 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.76
Altman-Z 3.74
ROIC/WACC0.55
WACC7.05%
ALBKK.PA Yearly LT Debt VS Equity VS FCFALBKK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ALBKK has a Current Ratio of 2.23. This indicates that ALBKK is financially healthy and has no problem in meeting its short term obligations.
ALBKK's Current ratio of 2.23 is fine compared to the rest of the industry. ALBKK outperforms 71.88% of its industry peers.
ALBKK has a Quick Ratio of 1.24. This is a normal value and indicates that ALBKK is financially healthy and should not expect problems in meeting its short term obligations.
ALBKK has a Quick ratio (1.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.24
ALBKK.PA Yearly Current Assets VS Current LiabilitesALBKK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 313.58% over the past year.
The Earnings Per Share has been growing slightly by 7.64% on average over the past years.
Looking at the last year, ALBKK shows a very strong growth in Revenue. The Revenue has grown by 32.61%.
The Revenue has been growing slightly by 3.34% on average over the past years.
EPS 1Y (TTM)313.58%
EPS 3Y-17.66%
EPS 5Y7.64%
EPS Q2Q%207.77%
Revenue 1Y (TTM)32.61%
Revenue growth 3Y2.06%
Revenue growth 5Y3.34%
Sales Q2Q%66.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBKK.PA Yearly Revenue VS EstimatesALBKK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALBKK is valuated rather expensively with a Price/Earnings ratio of 18.64.
68.75% of the companies in the same industry are more expensive than ALBKK, based on the Price/Earnings ratio.
ALBKK's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.21.
Industry RankSector Rank
PE 18.64
Fwd PE N/A
ALBKK.PA Price Earnings VS Forward Price EarningsALBKK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALBKK is on the same level as its industry peers.
ALBKK's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 30.4
EV/EBITDA 11.86
ALBKK.PA Per share dataALBKK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of ALBKK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.44
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

ALBKK has a Yearly Dividend Yield of 3.64%.
Compared to an average industry Dividend Yield of 3.15, ALBKK pays a bit more dividend than its industry peers.
ALBKK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 3.64%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALBKK.PA Yearly Dividends per shareALBKK.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
ALBKK.PA Yearly Income VS Free CF VS DividendALBKK.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

More info and screens

BAIKOWSKI SAS

EPA:ALBKK (5/9/2025, 7:00:00 PM)

19.198

+1 (+5.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.25%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap70.65M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.64%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.64
Fwd PE N/A
P/S 1.48
P/FCF 30.4
P/OCF 10.78
P/B 1.54
P/tB 1.79
EV/EBITDA 11.86
EPS(TTM)1.03
EY5.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.63
FCFY3.29%
OCF(TTM)1.78
OCFY9.27%
SpS12.96
BVpS12.44
TBVpS10.7
PEG (NY)N/A
PEG (5Y)2.44
Profitability
Industry RankSector Rank
ROA 5.47%
ROE 8.28%
ROCE 5.24%
ROIC 3.85%
ROICexc 4.28%
ROICexgc 4.9%
OM 6.12%
PM (TTM) 7.95%
GM 58.07%
FCFM 4.87%
ROA(3y)5.5%
ROA(5y)5.78%
ROE(3y)8.43%
ROE(5y)9.14%
ROIC(3y)4.4%
ROIC(5y)4.46%
ROICexc(3y)5.21%
ROICexc(5y)5.32%
ROICexgc(3y)6.11%
ROICexgc(5y)6.27%
ROCE(3y)5.99%
ROCE(5y)6.08%
ROICexcg growth 3Y-24.8%
ROICexcg growth 5Y2.36%
ROICexc growth 3Y-24.04%
ROICexc growth 5Y2.87%
OM growth 3Y-22.94%
OM growth 5Y-0.34%
PM growth 3Y-19.29%
PM growth 5Y4.18%
GM growth 3Y-5.48%
GM growth 5Y-1.45%
F-Score6
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.76
Debt/EBITDA 1.27
Cap/Depr 114.24%
Cap/Sales 8.87%
Interest Coverage 7.08
Cash Conversion 99.02%
Profit Quality 61.34%
Current Ratio 2.23
Quick Ratio 1.24
Altman-Z 3.74
F-Score6
WACC7.05%
ROIC/WACC0.55
Cap/Depr(3y)92.13%
Cap/Depr(5y)70.79%
Cap/Sales(3y)7.58%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)313.58%
EPS 3Y-17.66%
EPS 5Y7.64%
EPS Q2Q%207.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.61%
Revenue growth 3Y2.06%
Revenue growth 5Y3.34%
Sales Q2Q%66.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9306.45%
EBIT growth 3Y-21.36%
EBIT growth 5Y2.99%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y196.59%
FCF growth 3Y-35.63%
FCF growth 5YN/A
OCF growth 1Y735.71%
OCF growth 3Y-14.23%
OCF growth 5Y51.06%